These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 29975559)

  • 1. Further Support for the Involvement of Genetic Variants Related to the Serotonergic Pathway in the Antidepressant Response in Children and Adolescents After a 12-Month Follow-Up: Impact of the
    Gassó P; Blázquez A; Rodríguez N; Boloc D; Torres T; Mas S; Lafuente A; Lázaro L
    J Child Adolesc Psychopharmacol; 2018 Dec; 28(10):711-718. PubMed ID: 29975559
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of regulatory TPH2 polymorphisms with higher reduction in depressive symptoms in children and adolescents treated with fluoxetine.
    Gassó P; Rodríguez N; Boloc D; Blázquez A; Torres T; Gortat A; Plana MT; Lafuente A; Mas S; Arnaiz JA; Lázaro L
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jul; 77():236-240. PubMed ID: 28456685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic and genetic variants in the HTR1B gene and clinical improvement in children and adolescents treated with fluoxetine.
    Gassó P; Rodríguez N; Blázquez A; Monteagudo A; Boloc D; Plana MT; Lafuente A; Lázaro L; Arnaiz JA; Mas S
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Apr; 75():28-34. PubMed ID: 28025020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
    Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I
    Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HTR2A gene variation is involved in antidepressant treatment response.
    Lucae S; Ising M; Horstmann S; Baune BT; Arolt V; Müller-Myhsok B; Holsboer F; Domschke K
    Eur Neuropsychopharmacol; 2010 Jan; 20(1):65-8. PubMed ID: 19758789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin receptor 2A (HTR2A) gene polymorphism predicts treatment response to venlafaxine XR in generalized anxiety disorder.
    Lohoff FW; Aquino TD; Narasimhan S; Multani PK; Etemad B; Rickels K
    Pharmacogenomics J; 2013 Feb; 13(1):21-6. PubMed ID: 22006095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of serotonin-related genes in antidepressant response.
    Peters EJ; Slager SL; McGrath PJ; Knowles JA; Hamilton SP
    Mol Psychiatry; 2004 Sep; 9(9):879-89. PubMed ID: 15052272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5HT1A and 5HT2A receptor genes in treatment response phenotypes in major depressive disorder.
    Noro M; Antonijevic I; Forray C; Kasper S; Kocabas NA; Lecrubier Y; Linotte S; Mendlewicz J; Montgomery S; Snyder L; Souery D; Verbanck P; Zohar J; Massat I
    Int Clin Psychopharmacol; 2010 Jul; 25(4):228-31. PubMed ID: 20453658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms in GRIK4, HTR2A, and FKBP5 show interactive effects in predicting remission to antidepressant treatment.
    Horstmann S; Lucae S; Menke A; Hennings JM; Ising M; Roeske D; Müller-Myhsok B; Holsboer F; Binder EB
    Neuropsychopharmacology; 2010 Feb; 35(3):727-40. PubMed ID: 19924111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic dysfunction of serotonin 2A receptor hampers response to antidepressant drugs: A translational approach.
    Qesseveur G; Petit AC; Nguyen HT; Dahan L; Colle R; Rotenberg S; Seif I; Robert P; David D; Guilloux JP; Gardier AM; Verstuyft C; Becquemont L; Corruble E; Guiard BP
    Neuropharmacology; 2016 Jun; 105():142-153. PubMed ID: 26764241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel sequence variations in the brain-derived neurotrophic factor gene and association with major depression and antidepressant treatment response.
    Licinio J; Dong C; Wong ML
    Arch Gen Psychiatry; 2009 May; 66(5):488-97. PubMed ID: 19414708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder.
    Lin E; Chen PS; Chang HH; Gean PW; Tsai HC; Yang YK; Lu RB
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1167-72. PubMed ID: 19560507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-Year Follow-up of Children and Adolescents with Major Depressive Disorder: Relationship between Clinical Variables and Abcb1 Gene Polymorphisms.
    Blázquez A; Gassó P; Mas S; Plana MT; Lafuente A; Lázaro L
    Pharmacopsychiatry; 2016 Nov; 49(6):248-253. PubMed ID: 27309038
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence and interaction of genetic, cognitive, neuroendocrine and personalistic markers to antidepressant response in Chinese patients with major depression.
    Bi Y; Ren D; Guo Z; Ma G; Xu F; Chen Z; An L; Zhang N; Ji L; Yuan F; Liu L; Hou B; Yang F; Yu S; Yi Z; Xu Y; He L; Sun X; Dong Z; Wu S; Zhao L; Cai C; Li X; Yu T; Shi Y; He G
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jan; 104():110036. PubMed ID: 32702381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of 5-HTR2A genetic polymorphisms on the efficacy of antidepressants in the treatment of major depressive disorder: a meta-analysis.
    Lin JY; Jiang MY; Kan ZM; Chu Y
    J Affect Disord; 2014 Oct; 168():430-8. PubMed ID: 25108775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetics in major depression: a comprehensive meta-analysis.
    Niitsu T; Fabbri C; Bentini F; Serretti A
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():183-94. PubMed ID: 23733030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.
    ; ;
    Am J Psychiatry; 2013 Feb; 170(2):207-17. PubMed ID: 23377640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variation in the calcium/calmodulin-dependent protein kinase (CaMK) pathway is associated with antidepressant response in females.
    Shi Y; Yuan Y; Xu Z; Pu M; Wang C; Zhang Y; Liu Z; Wang C; Li L; Zhang Z
    J Affect Disord; 2012 Feb; 136(3):558-66. PubMed ID: 22119081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desvenlafaxine Versus Placebo in a Fluoxetine-Referenced Study of Children and Adolescents with Major Depressive Disorder.
    Weihs KL; Murphy W; Abbas R; Chiles D; England RD; Ramaker S; Wajsbrot DB
    J Child Adolesc Psychopharmacol; 2018 Feb; 28(1):36-46. PubMed ID: 29189044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early response and remission as predictors of a good outcome of a major depressive episode at 12-month follow-up: a prospective, longitudinal, observational study.
    Ciudad A; Álvarez E; Roca M; Baca E; Caballero L; García de Polavieja P; Casillas M; Valladares A; Gilaberte I
    J Clin Psychiatry; 2012 Feb; 73(2):185-91. PubMed ID: 22053897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.